FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2530123654> ?p ?o ?g. }

• W2530123654 abstract "Abstract The pathophysiology of thrombotic thrombocytopenic purpura (TTP) relates the ADAMTS 13 protease deficiency as a result of an inhibitor in acquired TTP, such as secondary to malignancy. Relapsing TTP is due to the inhibition or relative deficiency of von Willibrand factor (vWf)-cleaving protease activity preventing the breakdown of unusually large multimers of vWf, with resultant platelet adhesion to the subendothelium, platelet aggregation, and endothelial damage (Nabhan, 2003). We describe the manifestation of TTP as marker for rectal cancer disease recurrence and progression. A 60 y/o black male with Dukes C2 rectal cancer was treated with surgical resection, local radiation and six months of adjuvant fluoruracil and leucovorin. Two years later, he presented with fatigue, shortness of breath and confusion. He had a hemoglobin of 7.0 g/dl, platelets of 20,000, 2+ schistocytes, and acute renal failure with a creatinine of 1.5 mg/dl. TTP was confirmed with decreased ADAMTS 13 protease activity <6%(nl 67–177%) and the presence of an ADAMTS 13 inhibitor of 0.5u (nl 0–0.4u). Plasmaphoresis and high dose steroids were initiated with very good response. His evaluation revealed a carcinoembryonic antigen (CEA) of 11.4 μg/L (normal <3.0 μg/L) and CT scan showed a new solitary liver mass. After optimal response from plasmapheresis, the liver lesion was surgically resected and pathology confirmed metastatic rectal adenocarcinoma. His TTP improved and after resection his ADAMTS 13 inhibitor was <0.4 and ADAMTS activity had improved to 49%, but was not normal. This suggests that the resection was not curative. He was tapered off plasmaphoresis for several months. TTP relapse occurred, with ADAMTS inhibitor present at 0.9 IU and activity of <6%, prior to confirmation of numerous new hepatic lesions on CT scan. Palliative chemotherapy with FOLFIRI (irenotecan, 5-FU, and leucovorin) achieved a partial remission of his rectal cancer. He also had a good therapeutic response for his relapsed TTP, with improved ADAMTS 13 activity to 27%, but continued to required weekly maintenance plasmapheresis prior to chemotherapy. Progression of his rectal cancer was preceded by relapsed TTP, requiring intensification of treatment with increased frequency of plasmapheresis. CT scan and rising CEA confirmed rectal cancer progression, and his chemotherapy was changed to XELOX (capecitabine and oxaliplatin). Response to chemotherapy correlated with stable disease with regards to his TTP. Thrombotic thrombocytopenic purpura and the related hemolytic uremic syndrome (HUS) are rare, but well described complications in patients with adenocarcinomas, including gastrointestinal, pancreatic, breast and prostate primaries. TTP has also been described following treatment with certain chemotherapeutic agents, including cisplatin, gemcitabine, bleomycin and mitomycin C. Only one case has been reported in the literature of TTP relapse at the time of tumor progression, and this was a patient with breast cancer (Amer. J. Clin. Oncology23(1): 74-7, 2000). However, there is no report of recurrent TTP-HUS serving as a marker for solid tumor disease recurrence with correlative ADAMTS 13 protease activity and inhibitor. We conclude that effective treatment of the primary adenocarcinoma is crucial to the control of malignancy associated thrombotic thrombocytopenic purpura, and ADAMTS 13 inhibiter and activity levels are important clinical indicators of disease progression and response to treatment." @default.
• W2530123654 created "2016-10-21" @default.
• W2530123654 creator A5023297626 @default.
• W2530123654 creator A5031991459 @default.
• W2530123654 creator A5057105099 @default.
• W2530123654 date "2004-11-16" @default.
• W2530123654 modified "2023-09-27" @default.
• W2530123654 title "Thrombotic Thrombocytopenic Purpura as a Marker for Disease Progression in a Patient with Metastatic Rectal Cancer." @default.
• W2530123654 doi "https://doi.org/10.1182/blood.v104.11.4032.4032" @default.
• W2530123654 hasPublicationYear "2004" @default.
• W2530123654 type Work @default.
• W2530123654 sameAs 2530123654 @default.
• W2530123654 citedByCount "0" @default.
• W2530123654 crossrefType "journal-article" @default.
• W2530123654 hasAuthorship W2530123654A5023297626 @default.
• W2530123654 hasAuthorship W2530123654A5031991459 @default.
• W2530123654 hasAuthorship W2530123654A5057105099 @default.
• W2530123654 hasConcept C121608353 @default.
• W2530123654 hasConcept C126322002 @default.
• W2530123654 hasConcept C143998085 @default.
• W2530123654 hasConcept C2776694085 @default.
• W2530123654 hasConcept C2778585876 @default.
• W2530123654 hasConcept C2779788118 @default.
• W2530123654 hasConcept C526805850 @default.
• W2530123654 hasConcept C71924100 @default.
• W2530123654 hasConcept C89560881 @default.
• W2530123654 hasConcept C90924648 @default.
• W2530123654 hasConceptScore W2530123654C121608353 @default.
• W2530123654 hasConceptScore W2530123654C126322002 @default.
• W2530123654 hasConceptScore W2530123654C143998085 @default.
• W2530123654 hasConceptScore W2530123654C2776694085 @default.
• W2530123654 hasConceptScore W2530123654C2778585876 @default.
• W2530123654 hasConceptScore W2530123654C2779788118 @default.
• W2530123654 hasConceptScore W2530123654C526805850 @default.
• W2530123654 hasConceptScore W2530123654C71924100 @default.
• W2530123654 hasConceptScore W2530123654C89560881 @default.
• W2530123654 hasConceptScore W2530123654C90924648 @default.
• W2530123654 hasLocation W25301236541 @default.
• W2530123654 hasOpenAccess W2530123654 @default.
• W2530123654 hasPrimaryLocation W25301236541 @default.
• W2530123654 hasRelatedWork W1502347726 @default.
• W2530123654 hasRelatedWork W2010978111 @default.
• W2530123654 hasRelatedWork W2088611761 @default.
• W2530123654 hasRelatedWork W2117133507 @default.
• W2530123654 hasRelatedWork W2381416288 @default.
• W2530123654 hasRelatedWork W2979553236 @default.
• W2530123654 hasRelatedWork W2994265345 @default.
• W2530123654 hasRelatedWork W3130176112 @default.
• W2530123654 hasRelatedWork W4210409062 @default.
• W2530123654 hasRelatedWork W2554727304 @default.
• W2530123654 isParatext "false" @default.
• W2530123654 isRetracted "false" @default.
• W2530123654 magId "2530123654" @default.
• W2530123654 workType "article" @default.